NUP98 gene fusions in hematologic malignancies

被引:78
作者
Lam, DH
Aplan, PD
机构
[1] Natl Canc Inst, Dept Genet, Med Branch, Div Clin Sci,Adv Technol Ctr, Gaithersburg, MD 20877 USA
[2] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA
关键词
NUP98; acute leukemia; myelodysplastic syndrome; 11p15.5; translocations;
D O I
10.1038/sj.leu.2402269
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute leukemia Is associated with a wide spectrum of recurrent, non-random chromosomal translocations. Molecular analysis of the genes involved In these translocations has led to a better understanding of both the causes of chromosomal rearrangements as well as the mechanisms of leukemic transformation. Recently, a number of laboratories have cloned translocations involving the NUP98 gene on chromosome 11p15.5, from patients with acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), chronic myelogenous leukemia (CIVIL), and T cell acute lymphoblastic leukemia (T-ALL). To date, at least eight different chromosomal rearrangements involving NUP98 have been identified. The resultant chimeric transcripts encode fusion proteins that juxtapose the N-terminal GLFG repeats of NUP98 to the C-terminus of the partner gene. Of note, several of these translocations have been found In patients with therapy-related acute myelogenous leukemia (t-AML) or myelodysplastic syndrome (t-MDS), suggesting that genotoxic chemotherapeutic agents may play an important role in generating chromosomal rearrangements involving NUP98.
引用
收藏
页码:1689 / 1695
页数:7
相关论文
共 86 条
[1]  
Ahuja HG, 2000, CANCER RES, V60, P6227
[2]   The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion [J].
Ahuja, HG ;
Felix, CA ;
Aplan, PD .
BLOOD, 1999, 94 (09) :3258-3261
[3]  
Ahuja HG, 2000, GENE CHROMOSOME CANC, V29, P96, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1013>3.0.CO
[4]  
2-T
[5]   Heterogeneous fusion transcripts involving the NUP98 gene and HOXD13 gene activation in a case of acute myeloid leukemia with the t(2;11)(q31;p15) translocation [J].
Arai, Y ;
Kyo, T ;
Miwa, H ;
Arai, K ;
Kamada, N ;
Kita, K ;
Ohki, M .
LEUKEMIA, 2000, 14 (09) :1621-1629
[6]   The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10 [J].
Arai, Y ;
Hosoda, F ;
Kobayashi, H ;
Arai, K ;
Hayashi, Y ;
Kamada, N ;
Kaneko, Y ;
Ohki, M .
BLOOD, 1997, 89 (11) :3936-3944
[7]   The C-terminal domain of TAP interacts with the nuclear pore complex and promotes export of specific CTE-bearing RNA substrates [J].
Bachi, A ;
Braun, IC ;
Rodrigues, JP ;
Panté, N ;
Ribbeck, K ;
Von Kobbe, C ;
Kutay, U ;
Wilm, M ;
Görlich, D ;
Carmo-Fonseca, M ;
Izaurralde, E .
RNA, 2000, 6 (01) :136-158
[8]   Karyopherin beta 2 mediates nuclear import of a mRNA binding protein [J].
Bonifaci, N ;
Moroianu, J ;
Radu, A ;
Blobel, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) :5055-5060
[9]   The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9 [J].
Borrow, J ;
Shearman, AM ;
Stanton, VP ;
Becher, R ;
Collins, T ;
Williams, AJ ;
Dube, I ;
Katz, F ;
Kwong, YL ;
Morris, C ;
Ohyashiki, K ;
Toyama, K ;
Rowley, J ;
Housman, DE .
NATURE GENETICS, 1996, 12 (02) :159-167
[10]  
Buske C, 2000, BLOOD, V96, p573A